-
Something wrong with this record ?
Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect
S. Salamon, E. Podbregar, P. Kubatka, D. Büsselberg, M. Caprnda, R. Opatrilova, V. Valentova, M. Adamek, P. Kruzliak, M. Podbregar,
Language English Country United States
Document type Journal Article, Review, Research Support, Non-U.S. Gov't
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1999-01-01
- MeSH
- Adrenergic beta-Antagonists pharmacology MeSH
- Glucose metabolism MeSH
- Glycolysis MeSH
- Ischemia drug therapy metabolism MeSH
- Dichloroacetic Acid pharmacology MeSH
- Humans MeSH
- Neoplasms drug therapy metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis-even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?
b Medical Faculty University of Ljubljana Ljubljana Slovenia
e Weill Cornell Medicine in Qatar Qatar Foundation Education City Doha Qatar
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010854
- 003
- CZ-PrNML
- 005
- 20180418143558.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/01635581.2017.1263751 $2 doi
- 035 __
- $a (PubMed)28094552
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Salamon, Spela $u a Medical Faculty, University of Maribor , Maribor , Slovenia.
- 245 10
- $a Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect / $c S. Salamon, E. Podbregar, P. Kubatka, D. Büsselberg, M. Caprnda, R. Opatrilova, V. Valentova, M. Adamek, P. Kruzliak, M. Podbregar,
- 520 9_
- $a The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis-even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?
- 650 _2
- $a beta blokátory $x farmakologie $7 D000319
- 650 _2
- $a kyselina dichloroctová $x farmakologie $7 D003999
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ischemie $x farmakoterapie $x metabolismus $7 D007511
- 650 _2
- $a nádory $x farmakoterapie $x metabolismus $7 D009369
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Podbregar, Eva $u b Medical Faculty, University of Ljubljana , Ljubljana , Slovenia.
- 700 1_
- $a Kubatka, Peter $u c Department of Medical Biology , Jessenius Faculty of Medicine, Comenius University in Bratislava , Martin , Slovakia. d Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava , Martin , Slovakia.
- 700 1_
- $a Büsselberg, Dietrich $u e Weill Cornell Medicine in Qatar , Qatar Foundation-Education City , Doha , Qatar.
- 700 1_
- $a Caprnda, Martin $u f 2nd Department of Internal Medicine , Faculty of Medicine, Comenius University and University Hospital , Bratislava , Slovakia.
- 700 1_
- $a Opatrilova, Radka $u g Department of Chemical Drugs , Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic.
- 700 1_
- $a Valentova, Vanda $u c Department of Medical Biology , Jessenius Faculty of Medicine, Comenius University in Bratislava , Martin , Slovakia.
- 700 1_
- $a Adamek, Mariusz $u h Department of Thoracic Surgery , Faculty of Medicine and Dentistry, Medical University of Silesia , Katowice , Poland.
- 700 1_
- $a Kruzliak, Peter $u g Department of Chemical Drugs , Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic. i Department of Medical Physics and Biophysics , Faculty of Medicine, Pavol Jozef Safarik University , Kosice , Slovakia. j 2nd Department of Surgery , Faculty of Medicine, St. Anne's University Hospital and Masaryk University , Brno , Czech Republic.
- 700 1_
- $a Podbregar, Matej $u k Clinical Department for Anesthesiology and Intensive Care , University Medical Center Ljubljana , Slovenia.
- 773 0_
- $w MED00003569 $t Nutrition and cancer $x 1532-7914 $g Roč. 69, č. 2 (2017), s. 177-183
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28094552 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180418143658 $b ABA008
- 999 __
- $a ok $b bmc $g 1288339 $s 1007666
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 69 $c 2 $d 177-183 $e 20170117 $i 1532-7914 $m Nutrition and cancer $n Nutr Cancer $x MED00003569
- LZP __
- $a Pubmed-20180404